ORIX Begins Sales of Tera Protect Disinfectant
Jan 25, 2021
TOKYO, Japan - January 25, 2021 - ORIX Corporation (“ORIX”) announced today that it has entered into a joint business agreement with Santa Mineral Co., Ltd. to become the exclusive reseller of Tera Protect, a disinfectant derived from natural ingredients that it develops and produces. Sales of Tera Protect have now commenced.
Containing calcium hydrogen carbonate, which has virus-suppression properties, Tera Protect is produced using water and minerals extracted from plants via patented new technologies. It is completely free of chlorine and other harmful chemical substances.
These technologies leverage the synergistic effects of high alkalinity and terahertz radiation to remove virus-causing pathogens. Rikio Kirisawa, Professor of Veterinary Medicine at Rakuno Gakuen University and a co-researcher on the product, demonstrated the disinfectant was capable of removing 99.99% of virus-causing pathogens in approximately 25 types of animal viruses stored at the university*. At present, Tera Protect is used as a disinfectant at various public institutions, such as hospitals, schools, and nurseries.
Through this joint business, ORIX will encourage the extensive use of Tera Protect at medical institutions, hotels, restaurants, and other places of business. ORIX will also explore the possibility of partnerships with other manufacturers and retailers, with the aim of accelerating the popularization of Tera Protect. By working together with companies in wide-ranging industries, ORIX will promote the development of new products and services that use Tera Protect.
Going forward, ORIX will continue to focus on new technologies and services owned by small and medium-size enterprises. ORIX will support the sustainable growth of these companies by utilizing its sales networks and its ability to plan and propose new projects.
* Tera Protect is not capable of removing all viruses and bacteria. Please note that the virus- and bacteria-removing properties of Tera Protect have been verified under limited conditions and environments, and the efficacy of Tera Protect will depend on usage conditions and environments.
* Tera Protect is neither a pharmaceutical nor a quasi-pharmaceutical product.
|Company name||Santa Mineral Co., Ltd.|
|Address||2-6-4-1401 Hamamatsu-cho, Minato-ku, Tokyo|
|Description of business||Research, development, and production of Tera Protect and other products|
Investor Relations Team
Investor Relations and Sustainability Department
ORIX Corporation (TSE: 8591; NYSE: IX) is a financial services group which provides innovative products and services to its customers by constantly pursuing new businesses.
Established in 1964, from its start in the leasing business, ORIX has advanced into neighboring fields and at present has expanded into lending, investment, life insurance, banking, asset management, automobile related, real estate and environment and energy related businesses. Since entering Hong Kong in 1971, ORIX has spread its businesses globally by establishing locations in 34 countries and regions across the world.
Going forward, ORIX intends to utilize its strengths and expertise, which generate new value, to establish an independent ORIX business model that continues to evolve perpetually. In this way, ORIX will engage in business activities that instill vitality in its companies and workforce, and thereby contribute to society. For more details, please visit our website: https://www.orix.co.jp/grp/en/
(As of September 30, 2020)
Caution Concerning Forward Looking Statements:
These documents May contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with the United States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results” of the “Consolidated Financial Results April 1, 2019 – March 31, 2020.”
- View PDF of this release